Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 E Romie Ln
Ste A
Salinas, CA 93901Phone+1 831-755-1701
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2010 - 2013
NYC Health & Hospitals/South Brooklyn HealthResidency, Internal Medicine, 2007 - 2010
The Second Military Medicine UnivClass of 1990
Certifications & Licensure
CA State Medical License 2023 - 2025
PA State Medical License 2010 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
Publications & Presentations
PubMed
- Super-resolution imaging of T lymphocyte activation reveals chromatin decondensation and disrupted nuclear envelope.Jianquan Xu, Xuejiao Sun, Zhangguo Chen, Hongqiang Ma, Yang Liu
Communications Biology. 2024-06-10 - 1 citationsPerspective on quantitative phase imaging to improve precision cancer medicine.Yang Liu, Shikhar Uttam
Journal of Biomedical Optics. 2024-06-01 - 2 citationsToward drift-free high-throughput nanoscopy through adaptive intersection maximization.Hongqiang Ma, Maomao Chen, Phuong Nguyen, Yang Liu
Science Advances. 2024-05-24
Abstracts/Posters
- Pdox Models Empower Preclinical Drug Evaluation and Mechanistic Studies Via Faithful Recapitulation of the Pathology, Complex Heterogeneity, Genetic-Transcriptomic Lan...Yang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell LymphomaYang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- BI-1206, a Monoclonal Antibody Against Fc_riib, Showed Superior Anti-Tumor Activity in an Ibrutinib-Venetoclax Dual Resistant PDX Model in Mantle Cell LymphomaYang Liu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Clinical efficacy of tumor-treating fields for newly diagnosed glioblastoma.ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
- The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Maryland’s Institute of Human Virology Form New Theory to Improve Efficacy & Safety of Immunotherapy DrugsDecember 31st, 2019
Stand up to Cancer & Society for Immunotherapy of Cancer Award 5 Convergence FellowshipsAugust 7th, 2019
Umosm Institute of Human Virology Scientists Propose New Theory for Cancer ImmunotherapyFebruary 22nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
